StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
UTHRBullishAnalyst Target Updateanalyst
Medium materiality5/10

Raymond James raises United Therapeutics target to $720

Nov 4, 2026, 2:19 PM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Moderately bullish analyst update; the target implies upside from the posted price, but remains an analyst estimate.

AI summary

What happened, with direct paths to the underlying reporting

Raymond James raised its UTHR price target to $720, versus the posted price of $611.80. The shares are down 9% since the signal, providing context for the positive analyst revision.

  • Raymond James raised its UTHR target to $720 from an indicated price of $611.80.
  • UTHR is down 9% since the signal.

Key facts

  1. 01

    Target: $720

  2. 02

    Posted price: $611.8

  3. 03

    Analyst firm: Raymond James

  4. 04

    Analyst: Tiago Fauth

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event